Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Cannara Biotech Inc. is a Canada-based licensed cannabis producer focused on the cultivation, processing, and sale of premium and craft cannabis products. The company operates within the Canadian cannabis industry, primarily serving the adult-use recreational market, with a strategic emphasis on quality flower, concentrates, and derivative products. Its core revenue is generated through branded cannabis sales to provincial distributors, with a particularly strong market presence in Québec.
The company differentiates itself through in-house genetics, controlled indoor cultivation, and a brand portfolio positioned toward experienced consumers. Cannara Biotech Inc. was founded in 2017 and became publicly listed on the Toronto Stock Exchange in 2021. Since inception, the company has evolved from a development-stage cultivator into a scaled commercial producer with multiple cultivation and processing facilities, expanding its product breadth while maintaining a focus on operational efficiency and brand-driven growth.
Business Operations
Cannara Biotech Inc. conducts its operations through integrated cultivation, processing, and commercialization activities in Canada. Its primary business segments include Cannabis Cultivation, Cannabis Processing, and Branded Product Commercialization, with revenue generated from the wholesale sale of dried flower, pre-rolls, concentrates, and other cannabis formats to provincial cannabis authorities.
The company controls large-scale indoor cultivation and processing assets in Québec, notably in Valleyfield and Farnham, enabling seed-to-sale production under one corporate structure. Cannara markets products under proprietary brands such as Tribal, Nugz, and Orchid CBD, which are distributed nationally through provincial channels. Operations are domestic-only; there is no verified evidence of material international cannabis sales as of the most recent public disclosures.
Strategic Position & Investments
Cannara Biotech Inc.’s strategy centers on disciplined capacity utilization, genetic innovation, and brand penetration within high-volume provincial markets, especially Québec. Growth initiatives prioritize increasing yields, improving cultivation efficiency, and expanding product formats within existing regulatory frameworks rather than aggressive international expansion.
The company has invested significantly in proprietary genetics, automation, and environmental controls to support consistent quality and margin optimization. Cannara has not completed any transformative acquisitions based on publicly available filings; growth has been primarily organic. Its brand portfolio, including Tribal and Nugz, represents its most notable internal investments and is positioned to capture both premium and value-oriented consumer segments. No material joint ventures or external portfolio investments have been conclusively disclosed.
Geographic Footprint
Cannara Biotech Inc. is headquartered in Québec, Canada, with principal operations located in Valleyfield and Farnham, Québec. These facilities serve as the company’s primary cultivation, processing, and logistics hubs.
The company distributes products across multiple Canadian provinces, selling through government-controlled cannabis wholesalers. Its operational and revenue footprint is entirely concentrated in North America, specifically Canada, and there is no verified evidence of active production facilities or commercial operations outside the country.
Leadership & Governance
Cannara Biotech Inc. was founded by entrepreneurs with backgrounds in real estate development and operations, bringing a vertically integrated approach to cannabis production. The leadership team emphasizes operational discipline, cost control, and brand-led growth within regulated markets. The company is governed by a board of directors overseeing compliance, capital allocation, and long-term strategy.
Key executives include:
- Luc Tellier – President & Chief Executive Officer
- Zohar Krivor – Founder & Executive Chairman
- Philippe Cossette – Chief Financial Officer
Leadership roles and titles are based on public company disclosures; however, some executive responsibilities and board committee assignments vary slightly across reporting periods. Where discrepancies exist, data is inconclusive based on available public sources.